Disrupting the Landscape to Change the Way We Age
Developing novel therapeutics with a deep focus on modifying aging.
Who We Are
With a focus on prevention, we are developing a range of therapeutic interventions that modify the way we age.
The Opportunity
Robust investor returns facilitated by a unique and integrated pipeline.
Diverse Portfolio
Currently developing ten leading programs with a clearly defined route to market.
We've Got the Aging Market Covered
Using an integrated model, we cover the entire aging market with a variety of advanced therapeutic interventions that target the biology of aging to treat multiple indications.
What would you do with more life in your lifetime?
We’re on a mission to find out.
Our experienced team is developing therapeutic interventions that will enable people worldwide to live longer, healthier lives.
In the News
Juvenescence: Think aging up, rather than disease down
New CEO set to Marshall longevity with a pipeline that delivers immediate therapeutic benefit, but always has an eye on a future preventative angle.
Master Investor 2022: Our CEO, Dr. Greg Bailey, presents Juvenescence
The investment community is chasing a longer, healthier life like the rest of us. Dr. Greg Bailey, successful investor and CEO/co-founder of Juvenescence, delivers an overview of the company’s areas
The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’
What makes longevity one of the greatest investment opportunities in human history? And what are companies doing to make the future of longevity a reality? Dr. Gregory Bailey, MD, CEO of